Harvoni and rival hep C drugs look set for approval in England – but NHS England may have the last word on controlling costs, finds Andrew McConaghie. Patients in England with hepatitis C (HCV) will ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Harvoni comes as oral tablets and pellets that ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. The medication comes in two oral forms: tablets ...

Biocon didn’t disclose the price, but said it will make CIMIVIR-L at the fraction of Harvoni’s cost in the US. Photo: Hemant Mishra/Mint Hyderabad: Biocon Ltd, India’s largest ...

The Food and Drug Administration (FDA) has approved Harvoni (ledipasvir and sofosbuvir; Gilead) and Sovaldi (sofosbuvir; Gilead) for use in younger patients with chronic hepatitis C virus (HCV).

Gilead Sciences, Inc. announced today plans to launch authorized generic versions of Epclusa ® (sofosbuvir 400mg/velpatasvir 100mg) and Harvoni ® (ledipasvir 90mg/sofosbuvir 400mg), Gilead's leading ...

The two drugs will be available to all patients irrespective of the level and stage of infection, the office said in a statement on Tuesday. The brand-name drugs (sold as Harvoni or Epclusa) ...

Gilead Sciences Inc.GILD-0.96%decrease; red down pointing triangle on Tuesday said sales of hepatitis C drugs Harvoni and Sovaldi missed expectations and slumped in the third-quarter, as the ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA — Adolescents treated with Harvoni achieved 97% rates of sustained virologic response, similar to that ...

A $100 million ad blitz has whipped up patient demand for Harvoni, the $1,100-a-pill hepatitis C treatment, even as the drug’s price has drawn a barrage of lawsuits, state investigations, and sharp ...

Gilead Sciences consolidated its leading position in the hepatitis C virus (HCV) treatment market this week with approval for wider use of its Harvoni product in the ...